1 / 6
Laboratory Research Material
Livagen 20mg
- Compound
- Livagen
- Amount per vial
- 20 mg
- Form
- Lyophilized powder
- Packaging
- 1 × 3 mL vial, boxed
- Shipping
- FedEx 2DayShips from the U.S. Estimated arrival2 business days after dispatchWeekday dispatch · 4 p.m. ET cutoff
Delivery details
Estimated for in-stock orders using FedEx 2Day. Weekends and FedEx closures are excluded. Holiday pickups, destination and carrier delays can affect arrival. Alaska and Hawaii may take longer.
Free U.S. shipping on orders $199+
Important
Research Use Notice
All articles and product information provided on this website are for informational and educational purposes only. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.
Product Documentation
Details, specifications, and reviews
Description
Livagen 20 mg: research material
Buy Livagen 20 mg for laboratory research, supplied as lyophilized powder in one boxed 3 mL vial.
Livagen is a synthetic tetrapeptide associated with the KEDA sequence: lysine–glutamic acid–aspartic acid–alanine. Published work has examined its effects on chromatin in cultured cells.
Choose the material and presentation
The original enzyme-study record identifies Livagen as Lys-Glu-Asp-Ala. The four-residue sequence distinguishes it from KED, KEDG and KEDW references. A shared three-residue beginning does not establish equivalent materials or effects.
The 20 mg presentation states the labeled amount of dry material. Before method selection, compare the exact peptide identity and any stated chemical form with the available product records. A general term such as “bioregulator” does not replace that specification.
Livagen and chromatin measurements in lymphocytes
Khavinson and colleagues studied cultured lymphocytes obtained from older donors. Livagen increased ribosomal-gene activity and reduced condensation in examined chromatin regions, including pericentromeric structural heterochromatin. The paper investigated changes in chromosome organization and gene activity.
These were measurements in donor-derived cells, not a trial in people receiving Livagen. They do not establish liver regeneration, organism-level rejuvenation or a predictable outcome for a separately supplied vial. Retaining the cell type and measured endpoint makes the research more informative than a broad “anti-aging” description.
Product records and batch reports
Review the available batch reports and product files in the product documentation section. Match the lot and identity information before interpreting a purity or measured-content result.
Analytical testing of a batch and a biological experiment with cultured lymphocytes provide different evidence. Use the relevant method and material records for handling and experimental requirements; do not transfer a storage period or generic purity guarantee from a competitor page.
Additional information
| CAS No. | 107667-60-7 |
|---|---|
| Molecular Formula | C18H31N5O9 — reference molecule; excludes counterions and fillers |
| Molecular Weight | 461.5 g/mol — reference molecule; excludes counterions and fillers |
| Purity | ≥99% |
| Sequence | Lys-Glu-Asp-Ala |
| Synthesis Method | Solid-phase synthesis |
| Format | Lyophilized powder |
| Solubility | Water or validated laboratory buffer |
| Stability & Storage | Up to 24 months at -20°C. Avoid repeated freeze-thaw cycles. |
| Applications | In-vitro assay research, compound characterization, analytical method development |
| Appearance | White to off-white powder |
| Regulatory/Compliance | Not for human consumption. For research use only. |
| Safety Information | MSDS available upon request |
Only logged in customers who have purchased this product may leave a review.
Product documents
Product information and laboratory resources for this product.
Product & packaging information
Labeled amount, physical form and packaging for Livagen 20mg.
Revision 0.4 · 2026-10-05Download PDFLaboratory handling guide
General guidance for applicable lyophilized research materials. Not a product-specific SDS.
Revision 1.0 · 2026-09-22Download PDFGeneral guides & resources
Reading a COA & Verifying Your Lot
PDF · Revision 1.0Receiving, Storage & Traceability Record
PDF · Revision 1.0Research Use & Documentation Scope
PDF · Revision 1.0Need Assistance?
Questions about product documentation?
Our support team can assist with product records, lot information, order questions, and certificate verification.

There are no reviews yet.